Clinical Trial Update: MITRIS China Post Market Clinical Follow-up (PMCF) Study

View source ↗

Summary

Edwards Lifesciences reports a post-market clinical follow-up study (MITRIS China PMCF) for a mitral valve replacement device, currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Disease

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Valve Replacement | Status: RECRUITING